信州大学HOME

業績録
  1. ホーム
  2. 業績録
  3. 2012年 業績録

業績録

2012年 業績録

[4]

1.      Suzuki S, Nishio S, Takeda T, Komatsu M. Gender-specific regulation of response to thyroid hormone. Thyroid Res. 5: 1, 2012.

 

2.      Suzuki S, Nishio SI, Ishii H, Sato A, Takeda T, Komatsu M. Availability of self-recorded axillary temperature for assessment of thermic effects of food: relationship between HDL-cholesterol level and postprandial thermoregulation in type 2 diabetic patients. Exp Clin Endocrinol Diabetes. 120: 96-100, 2012.

 

3.      Inaba H, Suzuki S, Takeda T, Kobayashi S, Akamizu T, Komatsu M. Amiodarone-induced thyrotoxicosis with thyroid papillary cancer in multinodular goiter: case report. Med Princ Pract. 21: 190-192, 2012.

 

4.      Nagamura Y, Yamazaki M, Shimazu S, Tsukada T, Sakurai A. Application of an intracellular stability test of a novel missense menin mutant to the diagnosis of multiple endocrine neoplasia type 1. Endocr J. 59: 1093-1098, 2012.

 

5.      Nagamura Y, Yamazaki M, Shimazu S, Sano K, Tsukada T, Sakurai A. A novel splice site mutation of the MEN1 gene identified in a patient with primary hyperparathyroidism. Endocr J. 59: 523-530, 2012.

 

6.      Yamazaki M, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D, Yamada M, Uruno T, Horiuchi K, Sato A, Miyauchi A, Imamura M. Delay in the diagnosis of multiple endocrine neoplasia type 1: typical symptoms are frequently overlooked. Endocr J. 59: 797-807, 2012.

 

7.      Sakurai A, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D, Tamada M, Uruno T, Horiuchi K, Miyauchi A, Imamura M; MEN. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of multicenter database. Clin Endocrinol(Oxf). 76: 533-539, 2012.

 

8.      Sakurai A, Yamazaki M, Suzuki S, Fukushima T, Imai T, Kikumori T, Okamoto T, Horiuchi K, Uchino S, Kosugi S, Yamada M, Komoto I, Hanazaki K, Itoh M, Kondo T. Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the MEN Consortium of Japan. Endocr J. 59: 859-866, 2012.

 

9.      Nishio S, Gibert Y, Berekelya L, Bernard L, Brunard L, Guillot E, Le Bail JC, Sa nchez JA, Galzin AM, Triqueneaux G, Laudet V. Fasting induces CART down-regulation in the zebrafish nervous system in a cannabinoid receptor 1-dependent manner. Mol Endocrinol. 26: 1316-1326, 2012.

 

10.   鈴木悟, 駒津光久. 全身疾患と耳鼻咽喉科 内分泌. JOHNS. 28: 1403-1406, 2012.

 

11.   櫻井晃洋, 永村優央子, 山崎雅則, 島津智子, 佐野健司, 塚田俊彦. MEN1遺伝子に同定された塩基置換 変異か多型か? 日本内分泌学会雑誌. 88: 90-94, 2012.

 

12.   羽深美恵子, 櫻井晃洋, 山崎雅則, 駒津光久, 江口尚, 野見山哲生, 福嶋義光. 糖尿病の家族歴が患者の疾患認識に及ぼす影響について 糖尿病と遺伝の関係に関する患者の意識調査から. 糖尿病. 55: 185-192, 2012.

 

13.   鈴木悟, 駒津光久. 加齢に伴うエネルギー・糖代謝の変化. 日本臨床. 70: 51-55, 2012.

 

14.   樋渡大, 関戸貴志, 駒津光久. 膵臓における高血糖の急性毒性. 救急・集中治療. 24: 534-538, 2012.

 

15.   大久保洋輔, 竹重恵子, 駒津光久. 加齢に伴う耐糖能低下の機序. 内分泌・糖尿病・代謝内科. 35: 9-12, 2012.

 

16.   Xu X, Kanai H, Ookubo M, Suzuki S, Kato N, Sadamatsu M. Consideration of congenital hypothyroidism as the possible cause of autism. A New Look at Hypothyroidism: 243-256, 2012.

 

17.   Mori J, Sato Y, Komatsu M. Bariatric surgery on obese Type 2 diabetes patients. Advanced Barriatric and Metabolic Surgery: 275-280, 2012.

 

18.   駒津光久. 糖尿病患者の血糖管理‐薬物療法を中心に-. 臨床に役立つ最新血糖管理マニュアル: 10-18, 2012.

 

 

19.   駒津光久. 生活指導と自己管理. 糖尿病最新の治療2010-2012: 267-269, 2012.

前の業績録を見る < 一覧に戻る > 次の業績録を見る